2018 年灌注系统市场价值为 10.4475 亿美元,预计 2019 年至 2027 年的复合年增长率为 3.8%。
灌注是液体通过循环系统或淋巴系统流向器官或组织的过程,通常指将血液输送到组织中的毛细血管床。灌注是通过血液输送到组织的速率或每单位组织质量每单位时间的血液量(血流量)来衡量的。在大型手术期间,灌注必须由相关的医疗专业人员维持和管理,而不是仅依靠身体的体内平衡。灌注系统市场的增长 归因于心血管疾病患病率的上升、制药和生物技术行业的显著增长、器官移植需求的上升以及基于细胞的研究活动的上升,这些因素在灌注系统市场的增长中发挥着至关重要的作用。然而,昂贵的器官移植手术和器官移植手术捐赠者数量有限等挑战可能会影响预测期内市场的增长。另一方面,新兴国家的技术发展为未来几年的市场增长提供了重大机遇。
灌注系统市场预计将在疫情后出现大幅增长。由于封锁、旅行禁令和企业停业,COVID-19 影响了各国的经济和行业。COVID-19 危机使许多国家的公共卫生系统不堪重负,凸显了对卫生系统进行可持续投资的强烈需求。随着 COVID-19 疫情的进展,预计医疗保健行业的增长将出现下降。由于对体外诊断产品的需求增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,预计医疗保健专业人员的虚拟咨询将成为疫情后主流的医疗服务模式。随着远程医疗改变医疗服务,数字医疗将在未来几年继续蓬勃发展。此外,临床试验中断以及随后的药物上市延迟也有望为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将会出现并改变制药行业,未来几年市场也有望见证更多的垂直整合和合资企业。
市场洞察
灌注系统在医疗保健领域的应用日益广泛,推动灌注系统市场增长
心血管疾病 (CVD) 是心脏和血管疾病,包括脑血管病、冠心病、风湿性心脏病和其他疾病。导致死亡和困难的一些主要因素是吸烟、不健康饮食和缺乏运动,这些都会增加心脏病发作和中风的风险。心血管疾病是全球死亡的主要原因,它影响的人数比任何其他疾病都多。除了生活方式和习惯外,老年人更容易患心血管疾病。老年人群通常会在一生中表现出血管结构和功能的改变。因此,它增加了患心血管疾病的风险。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
心血管疾病在世界范围内的发病率不断上升。导致人群患上心血管疾病的关键因素是心血管疾病。心血管疾病是全世界死亡的主要原因。根据美国心脏病学会的数据,心血管疾病在美国造成近 80 万人死亡,约占死亡人数的三分之一。冠心病 (CHD) 是造成大多数心血管疾病死亡的原因,其次是中风和心力衰竭。近 9000 多万美国人被诊断出患有心血管疾病。此外,据称,在全球范围内,心血管疾病占所有死亡人数的 31% 左右,预计到 2030 年,心血管疾病的费用将达到约 10,440 亿美元。
在欧洲,心血管疾病 (CVD) 每年导致 390 万人死亡,欧盟 (EU) 死亡人数超过 180 万人。CVD 占欧洲所有死亡人数的 45.0%,占欧盟所有死亡人数的 37.0%。CVD 是所有国家男性和女性死亡的主要原因。因此,灌注系统需要在心脏手术期间绕过心肺功能,并有助于维持血液循环和身体的氧气含量。因此,由于各地区和各国心血管疾病的患病率不断上升,预测期内,用于治疗 CVD 的灌注系统的需求可能会增加市场。
灌注系统市场也受到制药和生物技术行业显著增长的推动。在过去几年中,制药和生物技术行业发展异常迅速。慢性病和急性病患病率的上升令人担忧,对药物、治疗、疫苗、抗生素等的需求也随之上升。技术进步帮助制造商轻松提高生产效率。这些制造商与合同研究组织 (CRO) 结盟,通过新药、新疗法、数字化发展和不断变化的法规,应对巨大的医疗保健挑战。此外,老年人口的增加导致医疗保健条件的恶化。根据世界卫生组织的数据,全球人口每年增长 1.24%,导致老年人口数量增加。
世界卫生组织还预计,到2030年,65岁至80岁年龄段人口的比例将从2000年的22%上升至28%。此外,根据Torreya经济模型2017发布的调查报告,截至2017年,制药业的规模比此前的估计增长了30%,是全球经济价值增长的五大行业之一。
此外,全球范围内,制药、生物制药和生物技术初创公司的数量正在不断增加。这些公司正在开发创新药物和治疗产品,并得到了各国政府的支持。因此,初创企业和成熟企业在药品和其他治疗产品的生产方面表现出巨大的增长。药品和治疗产品的生产需要灌注系统和灌注系统来生产从生物源获得的原材料。生物技术公司还从事农业、食品和饮料等行业的原材料生产。与制药行业相比,生物技术公司更需要灌注系统。因此,由于这些因素,灌注系统市场在未来几年可能会蓬勃发展。
器官移植是当患者的器官完全停止运作时进行的手术。器官移植通常针对心脏、肝脏和肾脏等器官。然而,慢性病病例的增加导致需要移植其他器官,例如肺、胰腺、角膜和血管组织等。器官移植被认为是现代医学界的一大进步。
导致心脏、肺脏、肝脏、肾脏和其他器官功能受损的慢性疾病的增多导致了器官移植数量的增加。器官移植手术在世界各地不断增加。例如,在西班牙,大约进行了 5,260 例移植手术,其中近 3,200 例为肾脏移植手术,约 1,200 例为肝脏移植手术。心脏移植手术数量约为 300 例,肺部移植手术数量接近 360 例。公私合作伙伴关系在移植协调员的帮助下为器官移植的改善做出了巨大贡献。发展中国家和发达国家都展示了大量器官移植手术。例如,印度和新加坡等发展中国家正在成为亚太地区的医疗旅游目的地。这些国家在提供更好和更先进的医疗服务方面正在不断发展。
根据 2017 年美国慢性肾脏病情况说明书,美国约有 3000 万人患有慢性肾脏病。同样,根据美国国家糖尿病、消化和肾脏疾病研究所的数据,近 661,000 名美国人患有肾衰竭,其中近 468,000 名患者正在接受透析,约 193,000 名患者接受了肾脏移植。因此,发病率的增加可能会在未来几年增加肾脏移植的需求。同样,据估计,心脏病患者数量的增加也将在未来推动市场发展。因此,器官移植需求的增加是灌注系统市场的主要驱动因素之一。
慢性病的增多、生物技术应用的优势正在促进广泛的细胞研究活动。基于细胞的分析有助于了解生物体的生物学挑战。研究和调查有助于了解疾病过程及其复杂性。基于细胞的分析有助于了解细胞信号传导、增殖、细胞凋亡、细胞遗传学、神经学、癌症等方面。
基于细胞的检测在制药、生物技术行业、研究机构和学术研究机构中广泛开展。制药和生物制药行业需要高效地将药物商业化。因此,制药和生物技术行业的基于细胞的检测是灌注系统增长的驱动因素。
合同研究组织还广泛开展基于细胞的检测,用于临床试验研究和其他过程。癌症等慢性疾病和其他遗传相关研究正在推动基于细胞的研究。例如,Charles River 提供基于人类原代细胞的检测服务,根据该公司发表的一篇文章,基于细胞的检测在未来可能会继续发展。它指出,基于细胞的检测有助于药物发现,因为体外与体内的相关性在药物开发中起着至关重要的作用。因此,在预测期内,日益增多的基于细胞的研究活动可能会推动灌注系统的发展。
基于类型的洞察
就类型而言,灌注系统市场细分为微流体灌注系统、小型哺乳动物器官灌注系统、生物反应器灌注系统、重力或压力驱动灌注系统。2018 年,按类型划分,生物反应器灌注系统部分占据灌注系统市场的最大份额,为 44.3%。
基于组件的洞察
根据组件,市场上的灌注系统分为灌注泵、氧合器、心肺机、监测系统、插管等。氧合器部分预计在预测期内以 4.4% 的复合年增长率增长。
灌注系统市场参与者正在采用产品发布和扩张策略来满足全球不断变化的客户需求,这也使他们能够在全球范围内维护自己的品牌名称。
灌注系统市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响灌注系统市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的灌注系统市场细分和地理位置。
- 获取灌注系统市场的区域特定数据
灌注系统市场报告范围
报告属性 | 细节 |
---|---|
2018 年市场规模 | 10.4亿美元 |
2027 年市场规模 | 14.4亿美元 |
全球复合年增长率(2018 - 2027) | 3.8% |
史料 | 2016-2017 |
预测期 | 2019-2027 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
灌注系统市场参与者密度:了解其对业务动态的影响
灌注系统市场正在快速增长,这得益于最终用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在灌注系统市场运营的主要公司有:
- 瑞普利根公司
- 默克公司
- Ala 科学仪器有限公司
- XVIVO 灌注
- 美敦力
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取灌注系统市场顶级关键参与者概述
灌注系统市场 – 按类型
- 微流体灌注系统
- 小型哺乳动物器官灌注系统
- 生物反应器灌注系统
- 重力或压力驱动灌注系统
灌注系统市场 – 按组件划分
- 灌注泵
- 氧合器
- 人工心肺机
- 监控系统
- 套管
- 其他的
灌注系统市场 – 按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- MEA 其他地区
南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 其余的骗局
公司简介
- 瑞普利根公司
- 默克公司
- Ala 科学仪器有限公司
- XVIVO 灌注
- 美敦力
- XENIOS AG(费森尤斯医疗保健股份公司两合公司)
- 洁定公司
- 泰尔茂株式会社
- LivaNova PLC
- 赛多利斯公司
- 哈佛生物科学
- 兰德
- Sanisure(Sani-Tech West, Inc.)
- AutoMate科学公司
- 乔布斯特技术有限公司
- APD(高级灌注诊断)
- Spectrum Medical, Transonic Systems Inc
- 有机氧
- 伊斯凯维公司
- 中科生物工程有限公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Wind Turbine Composites Market
- Green Hydrogen Market
- Medical Collagen Market
- Enzymatic DNA Synthesis Market
- Sleep Apnea Diagnostics Market
- Online Exam Proctoring Market
- Piling Machines Market
- Point of Care Diagnostics Market
- Artificial Intelligence in Defense Market
- Emergency Department Information System (EDIS) Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Perfusion Systems Market
- REPLIGEN CORPORATION
- Merck KGaA
- Ala Scientific Instruments, Inc.
- XVIVO Perfusion
- Medtronic
- XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
- TERUMO CORPORATION
- Getinge AB
- Harvard Bioscience
- OrganOx
Emerging Players
- Sartorius AG
- RAND
- LivaNova PLC
- Sanisure (Sani-Tech West, Inc.)
- AutoMate Scientific, Inc.
- APD (Advanced Perfusion Diagnostics)
- Spectrum Medical
- Transonic Systems Inc
- CESCO BIOENGINEERING CO., LTD.
- Jobst Technologies GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.